Company / Shareholders' Equity
Design Therapeutics, Inc. Shareholders' Equity History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$242.1M
FY2025
5-year range
-$11.3M / $277.7M
FY2021-FY2025
Trend
-12.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$11M to $242M over the past 4 years.
Based on SEC 10-K filings.
$242M in FY2025.
Improved from -$11M to $242M over the past 4 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shareholders' equity decreased 12.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $242.1M | -12.8% |
| FY2024 | $277.7M | +2554.1% |
| FY2021 | -$11.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026